Anthem Blue Cross and Blue Shield Virginia prior authorization, page 24
CPT code lookup
Each row is one code from the public prior authorization list. The description is the procedure or service name on that source row. This is not a coverage decision.
Prior authorization codes
| Code | Description | Source |
|---|---|---|
| 80197 | Assay Of Tacrolimus | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 31 Original policy |
| 80198 | Assay Of Theophylline | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 31 Original policy |
| 80199 | Tiagabine | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 31 Original policy |
| 80200 | Assay Of Tobramycin | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 31 Original policy |
| 80201 | Assay Of Topiramate | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 31 Original policy |
| 80202 | Assay Of Vancomycin | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 31 Original policy |
| 80203 | Zonisamide | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 31 Original policy |
| 80235 | Lacosamide | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 31 Original policy |
| 80285 | Voriconazole | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 31 Original policy |
| 80400 | Acth Stimulation Panel; Adrenal Insufficiency | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 31 Original policy |
| 80402 | Acth Stimulation Panel; 21 Hydroxylase Deficiency | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 31 Original policy |
| 80406 | Acth Stimulation Panel; 3 Beta-Hydroxydehydrogenase Deficiency | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 31 Original policy |
| 80408 | Aldosterone Suppression Eval Panel | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 31 Original policy |
| 80410 | Calcitonin Stimulation Panel | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 31 Original policy |
| 80412 | Corticotropic Releasing Hormone (Crh) Stimulation Panel | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 31 Original policy |
| 80414 | Chorionic gonadotropin stimulation panel; testosterone response This panel must include the following: Testosterone (84403 x 2 on 3 pooled blood samples) | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 31 Original policy |
| 80415 | Chorionic gonadotropin stimulation panel; estradiol response This panel must include the following: Estradiol, total (82670 x 2 on 3 pooled blood samples) | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 31 Original policy |
| 80416 | Renal Vein Renin Stimulation Panel | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 31 Original policy |
| 80417 | Peripheral Vein Renin Stimulation Panel | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 31 Original policy |
| 80418 | Combined Rapid Anterior Pituitary Eval Panel | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 31 Original policy |
| 80420 | Dexamethasone Suppression Panel, 48 Hr | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 32 Original policy |
| 80422 | Glucagon Tolerance Panel; Insulinoma | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 32 Original policy |
| 80424 | Glucagon Tolerance Panel; Pheochromocytoma | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 32 Original policy |
| 80426 | Gonadotropin Releasing Hormone Stimulation Panel | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 32 Original policy |
| 80428 | Growth Hormone Stimulation Panel | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 32 Original policy |
| 80430 | Growth Hormone Suppression Panel (Glucose Administration) | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 32 Original policy |
| 80432 | Insulin-Induced C-Peptide Suppression Panel | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 32 Original policy |
| 80434 | Insulin Tolerance Panel; Acth Insufficiency | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 32 Original policy |
| 80435 | Insulin Tolerance Panel; Growth Hormone Deficiency | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 32 Original policy |
| 80436 | Metyrapone Panel | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 32 Original policy |
| 80438 | Thyrotropin releasing hormone (TRH) stimulation panel; 1 hour This panel must include the following: Thyroid stimulating | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 32 Original policy |
| 80439 | Thyrotropin releasing hormone (TRH) stimulation panel; 2 hour This panel must include the following: Thyroid stimulating | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 32 Original policy |
| 81000 | Urinalysis, Dip Stick/Tablet Reagent; Non-Automated W/Microscopy | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 32 Original policy |
| 81001 | Urinalysis, Dip Stick/Tablet Reagent; Automated W/O Microscopy | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 32 Original policy |
| 81002 | Urinalysis, Dip Stick/Tablet Reagent; Non-Automated, W/O Microscopy | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 32 Original policy |
| 81003 | Urinalysis, Dip Stick/Tablet Reagent; Automated, W/O Microscopy | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 32 Original policy |
| 81005 | Urinalysis; Qualitative/Semiquantitative, Except Immunoassays | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 32 Original policy |
| 81007 | Urinalysis; Bacteriuria Screen, Except By Culture/Dipstick | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 32 Original policy |
| 81015 | Urinalysis; Microscopic Only | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 32 Original policy |
| 81020 | Urinalysis; 2 or 3 glass test | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 32 Original policy |
| 81025 | Urine Pregnancy Test, Visual Color Comparison Methods | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 32 Original policy |
| 81050 | Volume Measurement, Timed Collection, Each | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 32 Original policy |
| 81120 | IDH1 (isocitrate dehydrogenase 1 [NADP+], soluble) (eg, glioma), common variants (eg, R132H, R132C) | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 32 Original policy |
| 81121 | IDH2 (isocitrate dehydrogenase 2 [NADP+], mitochondrial) (eg, glioma), common variants (eg, R140W, R172M) | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 32 Original policy |
| 81161 | DMD (dystrophin) (eg, Duchenne/Becker muscular dystrophy) deletion analysis, and duplication analysis, if performed | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 32 Original policy |
| 81162 | BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full sequence analysis and full duplicatio | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 32 Original policy |
| 81163 | BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full sequence analysis | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 32 Original policy |
| 81164 | BRCA1 (BRCA1, DNA repair associated), BRCA2 (BRCA2, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full duplication/deletion analysis (ie, de | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 32 Original policy |
| 81165 | BRCA1 (BRCA1, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full sequence analysis | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 32 Original policy |
| 81166 | BRCA1 (BRCA1, DNA repair associated) (eg, hereditary breast and ovarian cancer) gene analysis; full duplication/deletion analysis (ie, detection of large gene rearrangements) | Virginia HMO/EPO standard precertification/prior authorization requirements, Pg 32 Original policy |